These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27570807)

  • 1. Data on IL-6 c.-174 G>C genotype and allele frequencies in patients with coronary heart disease in dependence of cardiovascular outcome.
    Reichert S; Schlitt A; Benten AC; Hofmann B; Schaller HG; Schulz S
    Data Brief; 2016 Sep; 8():1295-9. PubMed ID: 27570807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin 6 c.-174 CC genotype is a predictor for new cardiovascular events in patients with coronary heart disease within three years follow-up.
    Reichert S; Schlitt A; Benten AC; Hofmann B; Schaller HG; Schulz S
    Cytokine; 2016 Jul; 83():136-138. PubMed ID: 27131578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of floss/interdental brushes is associated with lower risk for new cardiovascular events among patients with coronary heart disease.
    Reichert S; Schlitt A; Beschow V; Lutze A; Lischewski S; Seifert T; Dudakliewa T; Gawe R; Werdan K; Hofmann B; Schaller HG; Schulz S
    J Periodontal Res; 2015 Apr; 50(2):180-8. PubMed ID: 24824149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary heart disease].
    Fu HX; Li GS; Li Y; Xu JL; Zhang JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):519-22. PubMed ID: 16842669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of polymorphism in IL-6 gene promoter with BMI, inflammatory factors, and pathogenesis and progression of CHD].
    Jia XW; Tian YP; Wang Y; Deng XX; Dong ZN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1270-5. PubMed ID: 18088482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
    Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events.
    Greisenegger S; Endler G; Haering D; Schillinger M; Lang W; Lalouschek W; Mannhalter C
    Thromb Res; 2003 Jun; 110(4):181-6. PubMed ID: 14512079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphisms of T149C and T950C genes in osteoprotegerin promoter sites and the relationship between serum osteoprotegerin levels and coronary heart disease].
    Zhao F; Zhao H; Zhang R; Ren M; Liu C; Liu S; Ma J; Song Y; Liu T; Zhang X; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):319-324. PubMed ID: 30914093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of genetic variations of cholesteryl ester transfer protein on atorvastatin treatment efficacy and clinical outcomes in patients with coronary artery disease].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2195-9. PubMed ID: 24169327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients.
    Antonicelli R; Olivieri F; Bonafè M; Cavallone L; Spazzafumo L; Marchegiani F; Cardelli M; Recanatini A; Testarmata P; Boemi M; Parati G; Franceschi C
    Int J Cardiol; 2005 Sep; 103(3):266-71. PubMed ID: 16098388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interleukin 6 Protein Level as well as a Genetic Variants, (rs1800795, rs1800797) Are Associated with Adverse Cardiovascular Outcomes within 10-Years Follow-Up.
    Schulz S; Rehm S; Schlitt A; Bitter K; Reichert S
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors.
    Lieb W; Pavlik R; Erdmann J; Mayer B; Holmer SR; Fischer M; Baessler A; Hengstenberg C; Loewel H; Doering A; Riegger GA; Schunkert H
    Int J Cardiol; 2004 Nov; 97(2):205-12. PubMed ID: 15458685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of genetic variants in TNFα for periodontal disease in a cohort of coronary patients.
    Schulz S; Schlitt A; Lutze A; Lischewski S; Seifert T; Dudakliewa T; Gawe R; Werdan K; Hofmann B; Gläser C; Schaller HG; Reichert S
    J Clin Periodontol; 2012 Aug; 39(8):699-706. PubMed ID: 22691114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
    Hernesniemi JA; Karhunen PJ; Oksala N; Kähönen M; Levula M; Rontu R; Ilveskoski E; Kajander O; Goebeler S; Viiri LE; Hurme M; Lehtimäki T
    Eur Heart J; 2009 Dec; 30(23):2939-46. PubMed ID: 19687159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of C-159T polymorphism in promoter region of CD14 and coronary heart disease].
    Li Y; Xiong XQ; Zhang PA; Ming KH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):687-90. PubMed ID: 16331574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.
    Nauck M; Winkelmann BR; Hoffmann MM; Böhm BO; Wieland H; März W
    J Mol Med (Berl); 2002 Aug; 80(8):507-13. PubMed ID: 12185451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization.
    Burzotta F; Iacoviello L; Di Castelnuovo A; Glieca F; Luciani N; Zamparelli R; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
    Am J Cardiol; 2001 Nov; 88(10):1125-8. PubMed ID: 11703956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.